About the Authors
- Daniel T. Patton
-
Affiliation Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
- Marcus D. Wilson
-
Affiliation Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
- Wendy C. Rowan
-
Affiliation Tool Monoclonal Antibody Group, GlaxoSmithKline Research and Development, Stevenage, United Kingdom
- Dalya R. Soond
-
Affiliation Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
- Klaus Okkenhaug
-
* E-mail: klaus.okkenhaug@bbsrc.ac.uk
Affiliation Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
Competing Interests
Klaus Okkenhaug is a paid consultant for GSK. Klaus Okkenhaug is employed by the BBSRC and has received research funding from the BBSRC, the Wellcome Trust and GSK. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DTP WCR KO. Performed the experiments: DTP MDW DRS. Analyzed the data: DTP MDW DRS KO. Wrote the paper: DTP DRS KO.